首页> 外文期刊>Journal of plastic, reconstructive & aesthetic surgery: JPRAS >Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants
【24h】

Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants

机译:乳房植入患者的风险相关联的大细胞淋巴瘤(BIA-ALCL)在与纹理乳房植入物重建后的3546名妇女的队列中长期进行长期

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: The risk of BIA-ALCL for patients with textured breast implants has been estimated between 1/2832 and 1/30,000 women. Existing studies estimating the numbers exposed and at risk, may have under reported cases, and/or lacked comprehensive follow-up. Our objective is to determine the risk of BIA-ALCL in a defined cohort of patients reconstructed with macro -textured breast implants and consistently followed long-term. Methods: A prospective cohort study was conducted in patients who underwent breast recon- struction by a single surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) from Decem- ber 1992 to December 2017. Major events related to implants were prospectively recorded. We identified cases of BIA-ALCL by cross-checking clinical, pathology and external records data. Patients were followed until lymphoma occurrence or last follow-up. The primary outcomes were incidence rate per person -years and cumulative incidence.
机译:背景:BIA-ALCL对纹理乳房植入患者的风险估计在1/2832和1 / 30,000名妇女之间。 现有的研究估计暴露和面临风险的数量可能在报告的情况下,和/或缺乏全面的随访。 我们的目的是确定在重建宏观乳房植入物的确定患者的定义群体中BIA-ALCL的风险,并始终如一的是长期的。 方法:通过1992年12月至2017年12月,在纪念斯隆kettering癌症中心(MSKCC)的单个外科医生接受乳房重建的患者中进行了预期队列研究。前瞻性地记录了与植入物相关的主要事件。 通过交叉检查临床,病理和外部记录数据,我们确定了BIA-ALCL的病例。 患者术后,直至淋巴瘤发生或最后一次随访。 主要结果是每人的发病率 - 年和累积发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号